Physician profile
Emily E Hoos
NPI 1386912913
$1,184.73
in general payments reported to CMS, 2019-2025
14 companies · $73.87 in 2025
The $73.87 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2022: $300 · 2023: $404 · 2024: $147 · 2025: $73.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $181.41 | 2022-2025 | Kimyrsa, Orbactiv, Vabomere |
| Janssen Pharmaceuticals, INC | $173.78 | 2021-2022 | |
| Shionogi INC | $145.71 | 2023-2024 | Fetroja |
| Takeda Pharmaceuticals U.S.A., INC. | $135.37 | 2022-2025 | Gattex |
| Chiesi USA, INC. | $132.92 | 2021-2023 | Cleviprex, Kengreal |
| Abbvie INC. | $125.00 | 2022 | |
| Alcresta Therapeutics, INC. | $76.28 | 2023-2024 | Relizorb |
| Fresenius Kabi USA, LLC | $55.44 | 2024-2025 | Smoflipid |
| La Jolla Pharmaceutical Company | $53.17 | 2023 | Xerava, Giapreza |
| Kci USA, INC. | $32.57 | 2022 | |
| Edwards Lifesciences Corporation | $29.20 | 2022 | |
| Smith+Nephew, INC. | $16.95 | 2021 | |
| Biocomposites INC | $15.44 | 2025 | Stimulan |
| Nestle Healthcare Nutrition INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Hoos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.